ZA975867B - Hypoglycemic and hypolipidemic compounds - Google Patents

Hypoglycemic and hypolipidemic compounds

Info

Publication number: ZA975867B
Authority: ZA; South Africa
Prior art keywords: hypoglycemic; compounds; hypolipidemic compounds; hypolipidemic; treating
Prior art date: 1996-07-01

Application number

ZA975867A

Other languages

English (en)

Inventor

Samuel James Dominianni

William Harlan Gritton

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-01

Filing date

1997-07-01

Publication date

1999-01-04

1997-07-01 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1999-01-04 Publication of ZA975867B publication Critical patent/ZA975867B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Obesity (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

ZA975867A 1996-07-01 1997-07-01 Hypoglycemic and hypolipidemic compounds ZA975867B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2101796P	1996-07-01	1996-07-01

Publications (1)

Publication Number	Publication Date
ZA975867B true ZA975867B (en)	1999-01-04

Family

ID=21801860

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA975867A ZA975867B (en)	1996-07-01	1997-07-01	Hypoglycemic and hypolipidemic compounds

Country Status (10)

Country	Link
US (1)	US6121282A (xx)
EP (1)	EP1019378B1 (xx)
JP (1)	JP2000515501A (xx)
AT (1)	ATE277907T1 (xx)
AU (1)	AU3513497A (xx)
CA (1)	CA2259431A1 (xx)
DE (1)	DE69731003D1 (xx)
IL (1)	IL121203A (xx)
WO (1)	WO1998000403A1 (xx)
ZA (1)	ZA975867B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200514783A (en)	1999-09-22	2005-05-01	Bristol Myers Squibb Co	Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
US6414002B1 (en)	1999-09-22	2002-07-02	Bristol-Myers Squibb Company	Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
HUP0203431A3 (en) *	1999-12-03	2003-11-28	Kyoto Pharma Ind	Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
US7187947B1 (en)	2000-03-28	2007-03-06	Affinity Labs, Llc	System and method for communicating selected information to an electronic device
WO2002096904A1 (en) *	2001-05-29	2002-12-05	Kyoto Pharmaceutical Industries, Ltd.	Novel heterocyclic derivatives and medicinal use thereof
KR20040030647A (ko) *	2001-05-29	2004-04-09	교토 야쿠힝 고교 가부시키가이샤	신규 복소환 화합물 및 그 의약 용도
US6924295B2 (en) *	2001-06-18	2005-08-02	Ono Pharmaceutical Co., Ltd.	Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient
US7548875B2 (en)	2001-06-27	2009-06-16	John Mikkelsen	Media delivery platform
US6716842B2 (en)	2002-04-05	2004-04-06	Warner-Lambert Company, Llc	Antidiabetic agents
PL374860A1 (en)	2002-07-09	2005-11-14	Bristol-Myers Squibb Company	Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
EP1630152A4 (en) *	2003-05-30	2009-09-23	Takeda Pharmaceutical	CONDENSED CYCLIC COMPOUND
JP4805552B2 (ja) *	2003-05-30	2011-11-02	武田薬品工業株式会社	縮合環化合物
WO2005080373A1 (en)	2004-02-04	2005-09-01	Pfizer Products Inc.	Substituted quinoline compounds
US20080186971A1 (en) *	2007-02-02	2008-08-07	Tarari, Inc.	Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
WO2012033195A1 (ja) *	2010-09-10	2012-03-15	京都薬品工業株式会社	複素環化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4988720A (en) *	1985-05-28	1991-01-29	Beecham Group P.L.C.	Novel treatment of hyperglycaemia
US4999363A (en) *	1988-06-09	1991-03-12	Kyowa Hakko Kogyo Co., Ltd.	Tricyclic compounds
US4902695A (en) *	1989-02-13	1990-02-20	Eli Lilly And Company	Excitatory amino acid receptor antagonists
AU6368090A (en) *	1989-10-03	1991-04-11	Warner-Lambert Company	Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity
US5036079A (en) *	1989-12-07	1991-07-30	Pfizer Inc.	Hypoglycemic thiazolidinedione derivatives
US5089514A (en) *	1990-06-14	1992-02-18	Pfizer Inc.	3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
DE69207560T2 (de) *	1991-06-07	1996-06-27	Otsuka Pharma Co Ltd	Antidiabetikum
US5246943A (en) *	1992-05-19	1993-09-21	Warner-Lambert Company	Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
DE69327572T2 (de) *	1992-05-21	2000-06-21	Otsuka Pharmaceutical Factory, Inc.	Phosphonsäurediester-derivat
US5236934A (en) *	1992-08-26	1993-08-17	E. I. Du Pont De Nemours And Company	1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
JP2845743B2 (ja) *	1992-12-28	1999-01-13	三菱化学株式会社	新規なナフタレン誘導体
GB9311661D0 (en) *	1993-06-05	1993-07-21	Smithkline Beecham Plc	Novel compounds
US5591862A (en) *	1993-06-11	1997-01-07	Takeda Chemical Industries, Ltd.	Tetrazole derivatives, their production and use
AU678625B2 (en) *	1993-09-30	1997-06-05	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US5571792A (en) *	1994-06-30	1996-11-05	Warner-Lambert Company	Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
US5616819A (en) *	1995-08-28	1997-04-01	Laroche Industries Inc.	Process for preparing fluorinated aliphatic compounds
US5885327A (en) *	1995-09-12	1999-03-23	Henkel Corporation	Process for the recovery of gold
DE19535243A1 (de) *	1995-09-22	1997-03-27	Bayer Ag	Neue Zwischenprodukte für die Synthese von Bisphosphinverbindungen

1997
- 1997-06-30 IL IL12120397A patent/IL121203A/en active IP Right Grant
- 1997-06-30 EP EP97931523A patent/EP1019378B1/en not_active Expired - Lifetime
- 1997-06-30 JP JP10504435A patent/JP2000515501A/ja not_active Ceased
- 1997-06-30 AU AU35134/97A patent/AU3513497A/en not_active Abandoned
- 1997-06-30 DE DE69731003T patent/DE69731003D1/de not_active Expired - Lifetime
- 1997-06-30 WO PCT/US1997/011514 patent/WO1998000403A1/en not_active Ceased
- 1997-06-30 CA CA002259431A patent/CA2259431A1/en not_active Abandoned
- 1997-06-30 AT AT97931523T patent/ATE277907T1/de not_active IP Right Cessation
- 1997-07-01 ZA ZA975867A patent/ZA975867B/xx unknown
1998
- 1998-12-18 US US09/216,470 patent/US6121282A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2259431A1 (en)	1998-01-08
ATE277907T1 (de)	2004-10-15
IL121203A (en)	2001-04-30
EP1019378A4 (en)	2001-09-26
US6121282A (en)	2000-09-19
IL121203A0 (en)	1997-11-20
EP1019378B1 (en)	2004-09-29
DE69731003D1 (de)	2004-11-04
EP1019378A1 (en)	2000-07-19
WO1998000403A1 (en)	1998-01-08
JP2000515501A (ja)	2000-11-21
AU3513497A (en)	1998-01-21

Similar Documents

Publication	Publication Date	Title
IL121203A0 (en)	1997-11-20	Hypoglycemic and hypolipidemic compounds
GR3026531T3 (en)	1998-07-31	Treatment for insulin dependent diabetes.
CA2329004A1 (en)	2000-01-06	Combination of insulin sensitizer with anorectic for treating or preventing diabetes
IL113141A0 (en)	1995-06-29	Intermediates for hypoglycemic hydroxyurea detivatives
NZ333588A (en)	2000-07-28	Sulphamates as anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS)
SE9502168L (sv)	1995-12-17	Insulinanalog-kompositioner
AU6785996A (en)	1997-03-27	2-alkylpyrrolidines
AU2490497A (en)	1998-01-08	Five beveled point geometry for a hypodermic needle
AU1839597A (en)	1997-08-11	Carpule$m(3) for an intraligamentary syringe
BR9505051A (pt)	1997-10-21	Composto derivado de 2,4-oxazolidinodiona processo para a sua produção e composição farmacêutica
AU7178498A (en)	1998-06-03	Prefillable syringes, plungers and injectors for use therewith
BR9810829B1 (pt)	2009-08-11	composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
MY113036A (en)	2001-11-30	Oral liquid formulation containing paroxetine
IL118426A (en)	2001-03-19	Pharmaceutical composition containing 1,3- bis-triazolyl-2-propanol derivative for treating cancer tumors or viruses
FI963508L (fi)	1996-09-06	3,5-disubstituoituja ja 3,5,6-trisubstituoituja 2-isoksatsoliineja ja isoksatsoleja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
IT1279684B1 (it)	1997-12-16	Siringa per iniezioni ipodermiche.
TW284777B (xx)	1996-09-01
BR9813996A (pt)	2000-09-26	2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
BR9100221A (pt)	1991-10-22	Composto;metodo para o tratamento de hipertensao,falha cardiaca congestiva ou glaucoma em um mamifero;e composicao farmaceutica
AU3770289A (en)	1990-02-05	Rifapentine hydrohalides
WO2001016111A3 (en)	2001-08-23	Hypoglycemic sulfonyl pyrazolones and pyrazolines
BG104139A (en)	2000-11-30	Diabetes treatment with thizolidindion and sulphonylurea
DE69630123D1 (en)	2003-10-30	Optische spaltung von 1-azabicylo(2.2.2)octan-3-amin,2-(diphenylmethyl)-n-((2-methoxy-5-(1-methylethyl)phenyl)methyl)
AU8829091A (en)	1992-06-11	Plunger mechanism for i.s. machine
GB9726630D0 (en)	1998-02-18	Kv2.1 Antagonists